SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070698-13-000079
Filing Date
2013-11-07
Accepted
2013-11-07 16:11:24
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q Q3-2013 FOR THE THREE & NINE MONTHS ENDED SEPTEMBER 30, 2013 rptp_10q_093013.htm 10-Q 1070108
2 CEO CERTIFICATION rptp_exh311.htm EX-31.1 9669
3 CFO CERTIFICATION rptp_exh312.htm EX-31.2 9330
4 CEO AND CFO CERTIFICATION rptp_exh321.htm EX-32.1 8996
  Complete submission text file 0001070698-13-000079.txt   7771225

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rptp-20130930.xml EX-101.INS 1162815
6 XBRL TAXONOMY EXTENSION SCHEMA rptp-20130930.xsd EX-101.SCH 50333
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20130930_cal.xml EX-101.CAL 58866
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20130930_def.xml EX-101.DEF 183356
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20130930_lab.xml EX-101.LAB 722765
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20130930_pre.xml EX-101.PRE 359362
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 131200757
SIC: 2834 Pharmaceutical Preparations